Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants

scientific article published on 13 December 2017

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants is …
instance of (P31):
scholarly articleQ13442814

External links are
P5530Altmetric DOI10.1053/J.GASTRO.2017.12.003
P6409CORE ID144581850
P6179Dimensions Publication ID1099660493
P356DOI10.1053/J.GASTRO.2017.12.003
P953full work available at URLhttp://eprints.whiterose.ac.uk/125742/
P932PMC publication ID5880715
P698PubMed publication ID29247777
P1154Scopus EID2-s2.0-85044608490

P50authorJesper LagergrenQ5931193
Carlos CaldasQ9696930
Leslie BernsteinQ60607806
Paul D P PharoahQ61822938
Shanshan ZhaoQ61832423
Nicholas J. ShaheenQ64749672
Anna H WuQ89864403
Marilie GammonQ104751082
Douglas A. CorleyQ110251065
Stomach and Oesophageal Cancer Study (SOCS) consortiumQ125294954
Matthew F BuasQ38360951
Puya GharahkhaniQ47502881
Laura J. HardieQ47944593
Bradley J KendallQ56449778
Weimin YeQ57055090
P2093author name stringJing Dong
Geoffrey Liu
David C Whiteman
Wong-Ho Chow
Harvey A Risch
Rebecca C Fitzgerald
Brian J Reid
Lesley A Anderson
Thomas L Vaughan
Lynn Onstad
Aaron P Thrift
Prasad G Iyer
Nigel C Bird
P2860cites workBarrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisQ24602426
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagusQ28943522
Cancer statistics, 2016Q29547383
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyondQ29614697
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Q30238753
Quality control and quality assurance in genotypic data for genome-wide association studiesQ30498925
A multibiomarker risk score helps predict risk for Barrett's esophagusQ33779408
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialQ33883502
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagusQ34298428
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization studyQ34354158
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic reviewQ34487254
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaQ58204833
The epidemic of oesophageal carcinoma: Where are we now?Q87241077
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisQ34537405
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusQ35042479
Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus.Q35149279
Precision prevention of oesophageal adenocarcinomaQ35243217
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON ConsortiumQ36504770
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
A clinical risk prediction model for Barrett esophagus.Q37114501
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal refluxQ37325010
Genomic prediction of coronary heart diseaseQ37487395
Prediction of Barrett's esophagus among men.Q37519245
Age at onset of GERD symptoms predicts risk of Barrett's esophagusQ37678177
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guideQ38193133
A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and preventionQ38921914
Prediction models need appropriate internal, internal-external, and external validationQ39005870
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic LociQ39326953
Risk assessment models for genetic risk predictors of lung cancer using two-stage replication for Asian and European populationsQ40040989
External Validation of the Michigan Barrett's Esophagus Prediction Tool.Q40289642
A review of goodness of fit statistics for use in the development of logistic regression modelsQ40338804
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer riskQ42952638
A model to determine absolute risk for esophageal adenocarcinoma.Q46881635
The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trendsQ47322343
Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few ValidatedQ48038405
Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.Q48874889
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.Q50875389
Barrett's oesophagusQ54290278
P407language of work or nameEnglishQ1860
P921main subjectadenocarcinomaQ356033
Barrett's esophagusQ808892
P577publication date2017-12-13
P1433published inGastroenterologyQ4039279
P1476titleDetermining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants

Reverse relations

cites work (P2860)
Q95488201Barrett oesophagus
Q54232649Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?
Q96953242Flaming the fight against cancer cells: the role of microRNA-93
Q92505682Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984-2013
Q89113888Natural History of Barrett's Esophagus
Q92968472Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis
Q92885531Synthetic circular multi-miR sponge simultaneously inhibits miR-21 and miR-93 in esophageal carcinoma
Q60960098The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy

Search more.